Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.894,95
1,60%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ BioXcel Therapeutics Inc (BTAI) BioXcel Therapeutics Inc (BTAI) Notizie

BioXcel Therapeutics Inc

BTAI
2,57
0,01 (0,39%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/4/202413:00GLOBEBioXcel Therapeutics to Report First Quarter 2024 Financial..
24/4/202416:30GLOBEBioXcel Therapeutics Announces Late-Breaking Abstract on..
22/4/202413:00GLOBEBioXcel Therapeutics Announces Plan for Evaluating BXCL501..
10/4/202413:00GLOBEBioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal..
25/3/202412:00GLOBEBioXcel Therapeutics Announces $25 Million Registered Direct..
15/3/202412:00GLOBEBioXcel Therapeutics Announces European Patent Office’s..
12/3/202412:00GLOBEBioXcel Therapeutics Reports Financial Results for the..
01/3/202413:00GLOBEBioXcel Therapeutics to Report Fourth Quarter and Full Year..
14/2/202413:00EDGAR2Form 8-K - Current report
13/2/202415:00GLOBEBioXcel Therapeutics Announces Termination of Proposed..
12/2/202418:45EDGAR2Form 8-K - Current report
12/2/202413:14GLOBEBioXcel Therapeutics Receives FDA Fast Track Designation for..
08/2/202423:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/2/202422:53EDGAR2Form 8-K - Current report
08/2/202422:01GLOBEBioXcel Therapeutics Announces Proposed Public Offering
08/2/202413:08EDGAR2Form 8-K - Current report
06/2/202413:00GLOBEBioXcel Therapeutics Announces Completion of Patient..
05/2/202413:00GLOBEBioXcel Therapeutics Announces USPTO’s Allowance of Patent..
23/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
12/1/202422:16EDGAR2Form S-3 - Registration statement under Securities Act of..
18/12/202322:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202313:22EDGAR2Form 8-K - Current report
12/12/202313:00EDGAR2Form 8-K - Current report
12/12/202313:00GLOBEBioXcel Therapeutics Hosting Virtual Neuroscience R&D Day..
11/12/202313:00GLOBEBioXcel Therapeutics Strengthens Clinical Development..
06/12/202313:00EDGAR2Form 8-K - Current report
30/11/202313:00GLOBEBioXcel Therapeutics to Host Virtual Neuroscience R&D Day on..
13/11/202317:59EDGAR2Form RW WD - Withdrawal of Registration Withdrawal Request
13/11/202316:23EDGAR2Form RW - Registration Withdrawal Request
08/11/202313:00GLOBEBioXcel Therapeutics Reports Positive Overall Survival..
06/11/202313:00GLOBEBioXcel Therapeutics Announces Update on NIDA-funded Trial..
02/11/202311:01EDGAR2Form S-3 - Registration statement under Securities Act of..
31/10/202312:00GLOBEBioXcel Therapeutics to Report Third Quarter 2023 Financial..
30/10/202312:00GLOBEBioXcel Therapeutics Receives Permanent J-Code for IGALMI™..
25/10/202316:30APSStrong Open For Biotech Shares Following Phase 3 Comments
25/10/202313:00GLOBEBioXcel Therapeutics Announces Positive Findings from..
19/10/202322:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/10/202313:06EDGAR2Form 8-K - Current report
10/10/202313:00GLOBEBioXcel Therapeutics Reports Positive Overall Survival..
04/10/202313:05EDGAR2Form 8-K - Current report
04/10/202313:00GLOBEBioXcel Therapeutics Provides Update on Recent Developments..
25/9/202323:07EDGAR2Form 8-K - Current report
20/9/202317:21EDGAR2Form 144 - Report of proposed sale of securities
20/9/202317:15EDGAR2Form 144 - Report of proposed sale of securities
19/9/202314:00EDGAR2Form 8-K - Current report
18/9/202322:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202322:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 2,60 Min: 2,56 Max: 2,6701
Chiusura: 2,56

La tua Cronologia

NASDAQ
BTAI
BioXcel Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network